The DCC protein and prognosis in colorectal cancer Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Cell Adhesion Molecules
  • Colorectal Neoplasms
  • Genes, DCC
  • Tumor Suppressor Proteins

abstract

  • DCC is a prognostic marker in patients with stage II or stage III colorectal cancer. In stage II colorectal carcinomas, the absence of DCC identifies a subgroup of patients with lesions that behave like stage III cancers. These findings may thus have therapeutic implications in this group of patients.

publication date

  • December 5, 1996

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJM199612053352303

PubMed ID

  • 8929264

Additional Document Info

start page

  • 1727

end page

  • 32

volume

  • 335

number

  • 23